The reduced risk of heart disease seen in people who are overweight or have obesity taking the weight loss drug semaglutide may not be due to a drop in weight alone. Results suggest that semaglutide should be considered as a cardiovascular disease reduction drug and not just as a weight loss drug.
ed.ac.uku/HectorJ — 21 days ago